Regulators announced on Thursday that the company responsible for ChatGPT will suggest solutions to address data privacy issues that led to a temporary ban of the AI chatbot in Italy.
The Garante, Italy’s data protection authority, recently halted the operations of OpenAI’s chatbot due to potential violations of European Union data privacy regulations. This decision requires the chatbot to cease processing the personal information of Italian users until further investigation is conducted.
According to experts, this is the first time democracy has implemented a nationwide prohibition on a mainstream AI platform.
Reas more: Expedia Partermes Up With ChatGPT To Plan Trips
During a video call on Wednesday, OpenAI executives, including CEO Sam Altman, committed to implementing measures to address concerns raised by the watchdog’s commissioners. However, the specific remedies have not yet been specified.
The Italian regulatory authority conveyed to OpenAI the significance of adhering to the EU’s strict data privacy regulations, without intending to hinder the progress of AI technology.
The ban was imposed by regulators due to the exposure of some users’ messages and payment information to others. Additionally, there were questions raised about the legal basis for OpenAI to collect large amounts of data used to train ChatGPT’s algorithms. Concerns were also expressed that the system could potentially generate false information about individuals.
Featured News
Microsoft President Grilled on Security and China Ties in Congressional Hearing
Jun 16, 2024 by
CPI
EU Set to Approve Lufthansa’s 41% Stake Acquisition in ITA Airways
Jun 16, 2024 by
CPI
Apple and Meta Face Imminent Charges Under EU Digital Markets Act
Jun 16, 2024 by
CPI
Discover Financial Services’ Pulse Network Settles Antitrust Lawsuit Against Visa
Jun 16, 2024 by
CPI
US Soccer Antitrust Battle Heads to Jury Trial
Jun 16, 2024 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 31, 2024 by
CPI
AI and Antitrust Considerations in U.S. Health Care
May 31, 2024 by
CPI
Uncertainty in the Bottom Line: New Antitrust Scrutiny and Enforcement in Private Equity Transactions
May 31, 2024 by
CPI
Effecting M&A Diligence When Competitors Are Involved
May 31, 2024 by
CPI
AI, Pharmaceutical Sector, and EU Competition Law and Policy: What Does the Future Look Like?
May 31, 2024 by
CPI